Recent News Stay up to date on the latest news about Abpro, including press releases and upcoming publications. News Press Releases Publications Press Releases JAN 22, 2024Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. IIRead More → SEP 21, 2023Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. IIRead More → SEP 21, 2022Abpro Finalizes Strategic Partnership with Celltrion for Worldwide Development and Commercialization of a Cancer Treatment Bispecific AntibodyRead More → News Prior to 2022 Publications November 6, 2019Abpro's TetraBi Platform for T-cell Engaging Antibodies targeting Claudin 18.2-expressing cancers Published for the 2019 SITC meetingRead More → MAY 16, 2019Abpro's TetraBi Platform for T-cell Engaging Antibodies Published for the 2019 ASCO MeetingRead More →
